文献速递消化系统肿瘤支持与姑息治疗

妊娠期胃癌22例临床病理特征与预后分析

[Data review and analysis of 22 cases of gastric cancer associated with pregnancy].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2018-01-01

该研究汇总中国医学科学院肿瘤医院2001—2016年收治的10例及国内数据库检索的12例妊娠期胃癌患者,分析其临床病理特征、治疗与预后。结果显示多数患者确诊时即为Ⅳ期(17例),病理以低分化腺癌(14例)和印戒细胞癌(7例)为主,1年生存率23.1%、2年生存率15.4%。

要点

  • 妊娠期胃癌多为Ⅳ期,腹膜和卵巢转移常见。
  • 病理以低分化腺癌和印戒细胞癌为主,预后差。
  • 晚期一线用铂类联合氟尿嘧啶,二线可选伊立替康或雷替曲塞。

核心结论

  • 妊娠期胃癌预后差,主要与分期晚和组织分化差有关。
  • 目前尚缺乏妊娠期胃癌的有效治疗策略。
  • 多数患者因分期晚无法行肿瘤切除。

研究设计与样本

  • 回顾性汇总2001—2016年中国医学科学院肿瘤医院收治的10例妊娠期胃癌患者。
  • 检索中国知网、万方数据库和维普数据库补充同期12例妊娠期胃癌患者,共22例。
  • 收集临床特征、病理学特征、TNM分期、治疗策略、胎儿及患者预后等信息。

主要发现

  • 常见症状为恶心呕吐(14例)、黑便(8例)、腹胀(7例)和腹痛(6例)。
  • 并发症包括消化道出血(9例)、肠梗阻(3例)和胃穿孔(2例)。
  • 病理为低分化腺癌14例、印戒细胞癌7例;分期Ⅰ期1例、Ⅳ期17例。
  • 腹膜转移7例、卵巢转移5例最为常见。
  • 1年生存率23.1%,2年生存率15.4%;3例R0切除患者生存超过18个月。

关键数值与推荐

  • 妊娠早期确诊3例行人工流产;妊娠中期5例中3例行引产。
  • 妊娠晚期3例确诊后立即行剖宫产手术。
  • 6例行胃癌根治性手术,5例行姑息手术。
  • 围手术期化疗主要为以奥沙利铂及氟尿嘧啶为主的2药或3药方案。
  • 晚期一线化疗以铂类和氟尿嘧啶类联合方案为主,二线以含伊立替康或雷替曲塞的方案为主。

临床怎么用

  • 妊娠期出现恶心呕吐、黑便、腹胀、腹痛等需警惕胃癌可能。
  • 确诊后需多学科协作,结合妊娠分期决定终止妊娠时机及抗肿瘤治疗。
  • 晚期患者一线考虑铂类联合氟尿嘧啶,二线可考虑伊立替康或雷替曲塞。

局限性

  • 样本量小(共22例),部分来自数据库检索,存在选择偏倚。
  • 原文未报告具体统计方法及随访时间等细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To assess the clinicopathological feature and prognosis of gastric cancer associated with pregnancy in Chinese population. Methods: We collected the clinical features, pathological findings, treatment modalities, the health status of infants and the information of prognosis for ten patients developed gastric cancer associated with pregnancy between 2001 and 2016 in our hospital and the counterpart 12 patients reported in China National Knowledge Internet (CNKI), Wanfang database and China Science and Technology Journal Database. Results: The most common symptoms were nausea and vomiting (n=14). Melena (n=8), abdominal distension (n=7) and abdominal pain (n=6) were also frequent. When considering the complications, gastrointestinal bleeding (n=9), intestinal obstruction (n=3) and gastric perforation (n=2) were common. The vast majority of pathology showed poorly differentiated tumors, poorly differentiated adenocarcinoma (n=14) and signet ring cell carcinoma (n=7). Only one patient was diagnosed at stage Ⅰ. And 17 patients developed metastatic disease of stage Ⅳ. Peritoneum (n=7) and ovary (n=5) were the most common metastasis sites. Three patients received abortion immediately after diagnosis in the first trimester of pregnancy. For the five patients in the second trimester of pregnancy, pregnancy termination was given to three patients. Caesarean section followed by gastrectomy was performed on three patients who were after the third trimester of gestation. Curative resection and palliative operation were carried out on six and five patients respectively. Combined chemotherapy based on oxaliplatin and fluorouracil was the common treatment for the peri-operative patients. For the metastatic gastric caner, platinum in combination with fluorouracil was recommended in the first line condition, irinotecan or raltitrexed were used in the second line treatment. One-year survival rate was 23.1%, and two-years survival was 15.4%. Three patients after R0 resection were alive without relapse over 18 months. Conclusions: The poor prognosis of gastric cancer associated with pregnancy may due to the late stage and the poor pathological type. There still lacks data of the appropriate treatment in these patients. It was demonstrated most patients have no chance of tumor resection due to the late stage. For the metastatic patients, platinum in combination with fluorouracil was recommended in the first line treatment. Irinotecan or raltitrexed were considered the choice for the second line treatment. 目的: 总结妊娠期胃癌的临床病理特点及预后。 方法: 2001—2016年中国医学科学院肿瘤医院收治的妊娠期胃癌患者10例和在中国知网、万方数据电子期刊数据库、维普电子期刊全文数据库检索到的同期妊娠期胃癌患者12例,收集患者的临床特征、病理学特征、TNM分期、治疗策略、胎儿及患者的预后等信息。 结果: 22例患者临床表现主要为恶心呕吐(14例)、黑便(8例)、腹胀(7例)和腹痛(6例)。并发消化道出血9例,肠梗阻3例,胃穿孔2例。低分化腺癌14例,印戒细胞癌7例。分期为Ⅰ期1例,Ⅳ期17例。腹膜转移(7例)和卵巢转移(5例)最为常见。3例于妊娠早期确诊的患者行人工流产手术。5例妊娠中期患者中,3例行引产手术。3例妊娠晚期患者均于确诊后立即行剖宫产手术。6例行胃癌根治性手术,5例行姑息手术。围手术期化疗方案主要为以奥沙利铂及氟尿嘧啶为主的2药或3药方案。晚期患者的一线化疗方案以铂类和氟尿嘧啶类的联合方案为主,二线化疗方案以含伊立替康或雷替曲塞的方案为主。22例妊娠期胃癌患者的1年生存率为23.1%,2年生存率为15.4%。3例接受R0切除的患者生存时间超过18个月。 结论: 组织分化差和分期晚是妊娠期胃癌患者预后差的主要原因。目前妊娠期胃癌尚缺乏有效治疗策略。由于分期晚,多数患者无法手术切除肿瘤。晚期患者的一线化疗方案以铂类和氟尿嘧啶类的联合方案为主,二线化疗方案以含伊立替康或雷替曲塞的方案为主。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Jiang ZC, Chi Y. [Data review and analysis of 22 cases of gastric cancer associated with pregnancy]. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 30139036. doi:10.3760/cma.j.issn.0253-3766.2018.08.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。